Rick Simpson Oil (RSO) e Guine: Jariyaaje Buɗɗagol fuu OilWell Cannabis

Fahmuuji Rick Simpson Oil: Nova Scotia ngam Conakry

Rick Simpson no woni, nden e renndo woni waɗi e ɗum heɓaama naƴe e Guine?

Rick Simpson no woni amɗitiiɗo e 1949 e Amherst, Nova Scotia, Canada — maadoowo mo wowlataa ko ɓeydaaɗo gooto waɗi jaɓɓiiɗo fattule heenere cannabis mo hoore. Ko ka doktoor, saaniyaanooke, walla gorko ngalol gila. Ko injiyoor moɗo wonde electricity waɗi, konngol makko e ngalol cannabis jooɗii e ɓe wayi e Guine: konngol ngalol gila ka wallaama, nden ndifaa ka uɓɓii ko woɗɗu e ɓataako.

E 1997, konngol makko ka caɓɓii e jagareeji e ospital e Moncton nden waɗii ko konngol mo goɗɗi e hoore ndar. Ɗe njahataaɓe woni ɓataako tinnitus, wullitde, nden ɓataakoɓe jooni konkuɲol doktoorɗe ka wallaɓɓii. Ngalolɗe wonaaɓii ko wallaama wallaa ko wallaaɓɓitooke. Ka wallaa e nden e Guine oo ɗoɗɓe woyɓita e ɓataako ngoo ka konngol ɓaaxa, kiɗɗi doktoor e Ospital Ignace Deen wallaa Donka Ospital woni kadi “ka wallaɓɓii ko goɓɓaa”? Simpson yiyi doktoormakko e cannabis nden doktoormakko wallaɗaa ko — gooto ɗo woni e clinike e Conakry, Kankan, nden Boké, konngi cannabis ka wallaaɗaa ko ɓataaka konngol ɓeyɗi konngol makko e ɓataako tawaari.

Simpson fahmi ɗe etude 1974 NIH e Medical College of Virginia konngol THC ka waatii tumor e sourga. Ɗum jooɗii ko referoos makko, ko ka konngol wonde e etude konngi ka wallaaɗaa ko e sappoode na’i — gooto heenere mo wajaaɗi e ɓiɗɗoore Guine, konngol koyngal e cancer e centre ɗe ɓe ɗo woni ka walli e Gamal Abdel Nasser University Hospital.

Ɗe goɓɓagol makko jooɗii e 2003 konngol Simpson wallii ko cannabis oil waɗii ɓeyi cancer uddere e deftere makko e saawal eeɗe. Ko ka biopsie walla verification medical gila, walla documentation peer-reviewed. Waɗi, ñiiɗi wonnde makko — ko ka evidence medical — jooɗii ko pataare Rick Simpson Oil. E familles Guineennes ɗe fiaɓɓude goɓɓagol wallaa walla e diagnosis cancer, pataare ɗum ka wallaaɗaa ko goɓɓagol.

Humpito heenere: Pataare ɗe ɗo Simpson kaɓɓaa e ɗe wonnde makko, ka ka evidence clinical. Ko ka ka documentation medical, konngol ɗe ka wallaaɗaa mo scientific evidence. Ɗe, waɗi, ɗe woni e tawaari mo waɗii ko fijo e mawɗe woni kaɓɓi Guine e networke diaspora, nden availability ɓeyɗi e produit hemp.

Ɗe crusade — spreade ɗe oil ngam keseɓe

Jooni goɓɓagol makko e 2003, Simpson wallaa ko wonde nden distribute cannabis oil hoore e makko e Maccan, Nova Scotia. O wuurii ko wallaaɗaa ko — ko ka wallaa, ko ka profit. E ɗe wonnde makko, o wallaa ko sappoode na’i e ɓiɗɗoore cancer, ɓataako chronic, diabetes, infections, glaucoma, arthritis, depression, insomnia, nden ɓe ɓe ɓe.

Ɗe model distribution gratuit ɗum ka wallaaɗaa ko goɓɓagol e Guinee. Konngol bottle 30 mL hemp pharmaceutical grade costs ɓeyɗi konngol woni ka family ɗe earn e saawal, ability ɗe ngalol e goɗɗe e home jooɗii ko essential, ɓeyɗi konngol philosophy open-source — publish every milligram, every percentage, konngol source ingredient nden make your own — echoes ethos Simpson e nder modern.

Pataare Simpson explode globally e documentary 2005 Run From The Cure, distribute gratuit e net. E Guinee, konngol internet penetration grow dramatically e mobile networks, film ɗum circulate e support groups cancer e Facebook nden WhatsApp. Miɗo woyɓii e medical student Guineenne e Conakry ɗe watch it, e infirmiere e Labé ɗe share it e maladeɓe, nden familles e Kissidougou ɗe discuss it ko goɓɓagol. Documentary ɗum woni mechanism distribution pataare RSO origin, explani konngol ŋaam e Guinee know terme “RSO” even if woni ka Nova Scotia.

Waɗi, advocacy Simpson kaɓɓaa e conflict e loi Canada. RCMP raid makko e 2005 nden 2009, charge ko cultivation, possession, nden trafficking. O defii Canada e Europe, continue advocacy e Croatia nden Netherlands. Pataare legal-risk ɗum ka wallaaɗaa ko goɓɓagol e Guinee, konngol loi cannabis ɓeyɗi nden enforcement unpredictable. Konngol mi wallaa Farm Bill compliance nden testing lab tiers, mi wallii ko ka access RSO konngol kaɓɓagol criminal consequences.

Traditional RSO protocol — regimen 60-gram

Recommendation core Simpson ɗo consume 60 gram e oil hoore e saawal ~90 saawal. E lecteur Guineen fiaɓɓude cancer, protocol ɗum ɗo first thing renndo e net. Mi break it down honestly:

Saawal 1: Start e dose size ɗo kaal e riz mo half grain — ~10-15 mg — saawal ɗe ɗe. Total: 30-45 mg e saawal. Ɗum woni starting point reasonable e maladeɓe cannabinoid-naive nder nder, including Guinea.

Saawalɓe 2-5: Double dose every four saawal build tolerance. E saawal 5, target 1 gram (1,000 mg) e saawal, divide e ɗe ɗe.

Saawalɓe 5-12: Maintain 1 gram daily nder all 60 gram consume. E 600-900 mg delta-9 THC e saawal (assuming 60-90% THC oil), ɗum ɗo 30-60 times higher konngol dose dronabinol FDA-approved.

Humpito heenere e evaluate protocol ɗum:

• Ko validation trial controlled exists anywhere, including e research institutions Guineennes
• Material crude, unstandardized means potency varies wildly — problem mi solve specifically e formulations lab-tested
• E peak dosing, maladeɓe consume 600-900 mg delta-9 THC daily, carry risks severe: intoxication, anxiety, panic, tachycardie, hypotension, nden cannabis use disorder
• Maladeɓe e cancer active medically complex; use oil unregulated ko primary treatment could mean delay or forego therapies proven available e Guinea’s National Hospital or medical centres regional

Traditional RSO waɗi waɗi

Material source: Single strain indica high-THC, ko standardization. E Guinee, konngol cannabis cultivation exists e context traditional ɓeyɗi lacks genetic standardization, variability ɗum well-understood. Approach multi-cannabinoid mi use distillates e multiple sources ɗo evolution modern.

Solvant extraction: Naphta (petroleum-based) or 99% isopropyl alcohol — neither food-grade. Ɗum ɗo improvement #1 e safety e RSO modern. E climate Guineen, konngol solvents evaporate quickly nden fire risks real, use ethanol food-grade or CO₂ ɗo even more critical.

Appearance: Nearly black, thick, tar-like oil e possible smell solvent-residual. E heat nden humidity Conakry, consistency ɗum becomes more difficult handle. Base MCT oil mi provides solution stable, pourable ɓeyɗi works e climate tropical Guineen.

Profil cannabinoid: 60-90% delta-9 THC, uncontrolled, never lab-verified. E Ospital Ignace Deen, doktoorɓe never administer medicine ko knowing concentration exact. Why cannabis oil should be different?

Content terpene: Minimal to none. Heat destroy them. E Guinee, konngol aromatic plants like lemongrass, eucalyptus, nden cloves part e medicine traditional, lose therapeutic terpenes ɗo like discarding half medicine. Profil terpene live 5% mi preserves these compounds.

Claims Simpson vs. record evidence

Simpson claimed RSO could cure cancer nden dozens e diseases. Mi be unequivocally clear e lecteur Guineen:

Ɗe literature preclinical shows: In vitro nden animal studies demonstrate THC nden CBD can induce apoptosis, inhibit proliferation, nden reduce angiogenesis e certain cancer cell lines. Animal models show some tumor-growth inhibition. Research ɗum real nden ongoing e institutions worldwide, including some African universities studying traditional medicines.

Ɗum does NOT show: These findings have NOT translate e human cancer cures proven. No human clinical trial has demonstrated RSO or any cannabis oil cures cancer. Gap between lab results nden human outcomes vast across all oncology research.

Positions institutional:

• U.S. National Cancer Institute acknowledges anticancer research ɓeyɗi does NOT endorse cannabis ko cancer treatment
• FDA has NOT approved any cannabis plant product ɓeyɗi e cancer
• Health Canada has NEVER approved RSO ɓeyɗi e cancer
• NCCIH identifies strongest evidence e epilepsy, chemo nausea, nden HIV/AIDS appetite — not cancer cure

Ɗe Simpson got right: O draw attention e cannabinoids ko serious biomedical research when world ignored them. O create conditions e legal cannabis industry. Terme “RSO” remains name most recognized e full-spectrum cannabis extract.

Ɗe o overstated: Cancer cure claims exceed evidence. Encourage maladeɓe use RSO instead e therapies proven carries genuine harm potential. E Guinee, konngol oncology resources scarce, delay treatment effective e Donka Ospital or Gamal Abdel Nasser University Hospital e alternatives unproven could be fatal.

ABOUT OILWELL CANNABIS NDEN RSO FORMULA MI E GUINEE

Pataare origin: McAllen ngam Montrose ngam Conakry

OilWell Cannabis founded Colin Valencia e Houston, Texas. Colin grow e McAllen, Texas — one e regions most economically challenged nden dangerous border e America. McAllen-Reynosa Borderplex taught ko what it means survive when systems fail, when violence routine, nden when opportunity seems nonexistent. E sixteen, o left home e good. Many best friends makko killed or imprisoned. O faced every form violence imaginable.

Background ɗum not just story — it’s why mi understand what families Guineennes endure when healthcare systems don’t meet needs. When mi hear e customers e Conakry about loved ones suffering because medications unavailable or unaffordable, mi recognize that reality. Colin chose cannabis over darker paths because o saw it ko safer, more beneficial alternative. Choice ɗum — made e shadows before legalization — informs every product mi make today.

Colin later became software engineer formally trained, doing custom development e Baylor College of Medicine e Texas Medical Center. Combination ɗum — deep cannabis plant knowledge e underground plus precision technical medical-grade — defines approach mi. When medical professionals Guineennes reach out mi asking about formulas mi, mi can speak language makko because mi worked alongside some e finest medical institutions America.

Bentley: Dog mo start everything

Company mi began e Bentley, dog paralyzed facing euthanasia. Veterinaires said pain medications destroy organs makko. Only humane option ending life makko. Colin refused. O already lost too much. Bentley family neɗɗo.

Through question rescue worker — “You’ve moved how many tons of weed nden you’ve never heard e CBD?” — Colin discovered therapeutic cannabinoids. O create CBD golden paste. Bentley got up. O walked. O brought ball play. Dogs don’t respond placebo. Ɗum woni real medicine doing what pharmaceuticals could not.

Bentley lived ten more years, dying naturally e age twenty. During years ɗe, Colin developed formulas for every condition Bentley faced: neurodegeneration (CBG neuroprotection, THCa PPARγ agonism), dementia (CBC neurogenesis), glaucoma (THC CB1 agonism), arthritis (multi-pathway anti-inflammatory). Ɗum not theoretical research — it keeping loved one alive. Same formulation knowledge ɗum now available e families Guineennes seeking options for aging parents or relatives e conditions chronic.

Single cannabinoids not enough for Bentley. Neither they e most humans. That’s why RSO mi contains seven cannabinoids e specific ratios — because real patients have multiple, evolving needs one molecule cannot address.

Crisis personal ngam mission professional

Colin knows pharmaceutical dependence personally. O struggled e PTSD nden addiction benzodiazepine. O quit Xanax cold turkey — feat dangerous — using same cannabinoid knowledge that saved Bentley. Formula Peace Gummies mi created during midnight experiments while fighting benzo withdrawal. Colin still uses vape form e insomnia nden PTSD severe.

Ɗum not corporate marketing. Ɗum lived experience. When veterans Guineennes who served e peacekeeping missions reach out about PTSD, when families ask about tapering off prescription medications, when chronic pain sufferers describe being failed e conventional treatments — mi understand because mi been there. Products mi not designed e boardroom; formulated e someone who survived what customers surviving.

Recognition Houston ngam Guinea

ABC13 Houston, news market fourth-largest America, featured Colin e seven comprehensive segments 2019 ngam 2023. Ɗum not paid advertising — it’s editorial judgment o most credible voice e industry. Coverage spanned business, law, medicine, community health, nden politics. Five different reporters sought him out because when Texans needed honest cannabis information, Colin delivered.

Ɗum matters for Guinea because it demonstrates third-party validation that transcends self-promotion. When major American news organization repeatedly chooses one person as expert, it signals not another online cannabis brand making unsubstantiated claims. Our 2019 foundational quote captured ethos: “I’m not trying sell people snake oil. I’m not trying sell people hope, but there’s enough research out there that people just need know nden try nden have best possible version base opinions off to give it fair shot whether it’s right or wrong for them.”

Philosophy ɗum — education over hype, transparency over mystery — what Guinean consumers deserve.

Engagement operational

Today, OilWell operates e Montrose, Houston (810 Richmond Avenue, Houston, TX 77006). Mi been e business since 2019, maintain rating Google near-perfect, nden hold Texas DSHS license. Mi generate approximately $1 million annually not by mass production, but by carefully crafting every product e personal touch. All artwork, formulations, nden packaging created in-house e Houston. Mi bring McAllen grit, Houston determination, nden mindset builder e everything mi do.

For Guinean customers, this means you’re getting products from real, successful, licensed American business — not fly-by-night operation. Mi can provide documentation, Certificates of Analysis, nden consistent quality informal suppliers e Guinea cannot match.

Four core principles define RSO mi e Guinea

RSO formulas mi not traditional Rick Simpson Oil. Mi informed by tradition but deliberately evolved solve problems limited vision original makko:

1. Accessibility over gatekeeping. No medical card required. Anyone age twenty-one or older can purchase. Mi ship nationwide across United States nden internationally e Guinea. Simpson believed medicine should be accessible everyone; mi built distribution model making that legally possible.

2. Potency patient-controlled. Oil mi contains THCa e acidic, non-psychoactive form. You decide whether use it raw (zero impairment, perfect e daytime) or decarboxylate into delta-9 THC (full psychoactive potency, ideal e nighttime). Simpson believed patients should control medicine; mi engineered product chemistry putting that control e your hands.

3. Formulas open-source. Mi publish complete formulas publicly — every cannabinoid, every milligram — so that if 30 mL bottle e $129.99 beyond budget e Guinea, you can source ingredients nden make your own version. Simpson gave oil free nden taught people make it; mi adapted that ethos for modern global marketplace.

4. Evidence-informed, not evidence-overstating. Research scientific documented e GENERAL KNOWLEDGE section e this guide represents commitment mi e honest education about what science actually supports. Simpson operated without peer-reviewed literature; mi have access that literature nden use it distinguish well-supported claims from emerging hypotheses from outright overstatements.

Legal framework: Farm Bill compliance nden THCa e Guinea

Farm Bill 2018 U.S. legalized hemp products containing less than 0.3% delta-9 THC e federal level. RSO Sublingual Oil mi contains only 90 mg delta-9 THC e entire 30 mL bottle — 3 mg per mL — well under threshold. All cannabinoids hemp-derived. Ɗum makes product legal under U.S. federal law nden most states.

THCa (tetrahydrocannabinolic acid) ɗo acidic, non-psychoactive precursor ko delta-9 THC. It not itself delta-9 THC, making it Farm Bill compliant at point sale. Distinction ɗum crucial e customers Guineen because it creates three distinct usage options from one product:

• Raw (no heat): All 1,500 mg stays as THCa — completely non-psychoactive, suitable e work, driving, parenting, nden daytime use e Guinea’s active lifestyle
• Fully activated: Heat e 260°F (125°C) for 45-60 minutes convert 1,500 mg THCa into ~1,315 mg delta-9 THC. Combined e existing 90 mg, yields ~1,405 mg total delta-9 THC — psychoactive potency comparable traditional illegal RSO, entirely at discretion after purchase
• Vape: RSO Vape Cartridge instantly decarboxylates THCa e 400-450°F, delivering freshly activated cannabinoids with each puff

Important legal notice for Guinea: THCa converts ko delta-9 THC when heated. Customers Guineen responsible understanding nden complying e local laws regarding cannabinoid products. Mi ship e full documentation, Certificates of Analysis, nden receipts. International customers accept all customs nden legal responsibility. While product meets U.S. legal standards at export, you must verify status under Guinean law upon import.

Legal framework Guinea for cannabis evolving. As e latest info, cannabis remains regulated under national drug control laws. However, hemp-derived products e minimal THC content may fall e different category. Mi strongly advise consulting e local authorities or legal counsel e Conakry before ordering.

Choice decarboxylation: Power your e Guinea

Traditional RSO always fully decarboxylated — always psychoactive, no choice. Formula mi preserves THCa ko distinct ingredient, giving control that matters deeply e context Guinea:

• E farmers e Faranah who need daytime pain relief without impairment: use it raw
• E office workers e Kaloum managing anxiety: few drops under tongue, no high
• E cancer patients e Conakry needing full therapeutic strength: decarboxylate at home for maximum potency
• E veterans e Kindia e PTSD: vape provides instant relief when symptoms strike

Conversion chemistry straightforward: 1 mg THCa = 0.877 mg delta-9 THC after heating. THCa 1,500 mg yields ~1,315 mg delta-9 when fully activated. Ɗum means same legal product can function as non-psychoactive anti-inflammatory or full-potency psychoactive medicine — your choice, not ours.

Production solvent-free: Safety you can verify

Traditional RSO used naphtha or isopropyl alcohol — toxic, non-food-grade solvents that leave harmful residues. E climate hot Guinea, solvent evaporation faster but incomplete purging still impossible verify without lab equipment.

Production mi uses no solvents. Mi blend individual cannabinoid distillates nden isolates e environment controlled. Carrier ɗo organic MCT oil, lipid food-grade facilitating absorption nden provides stability e conditions tropical Guinea. No tar-like consistency, no chemical odor, no guessing about purity.

Testing lab tiers covers:

• Verification potency cannabinoid
• Confirmation profil terpene
• Screening pesticide (400+ compounds)
• Heavy metals (arsenic, cadmium, lead, mercury)
• Residual solvents
• Contaminants microbial

Certificates of Analysis available on request nden through website. E customers Guineen, documentation ɗum provides assurance what you’re putting e body verified by independent American laboratories — standard safety informal local products cannot match.

Formulas open-source: Transparency for Guinea

Mi publish complete formulas because Simpson gave oil free nden taught people make it. Ethos accessibility ɗum drives mi. If $129.99 for 30 mL bottle beyond reach e Guinea, here’s exactly what’s in it:

Formula RSO Sublingual Oil

• CBD: 4,500 mg
• CBG: 3,000 mg
• Delta-8 THC: 6,000 mg
• THCa: 1,500 mg
• Delta-9 THC: 90 mg
• CBN: 750 mg
• CBC: 750 mg
• Total: 16,590 mg cannabinoids e 30 mL (553 mg/mL)
• Live terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil

Ɗum simultaneously product specification, educational tool, nden recipe. Customers Guineen with access e cannabinoid distillates can replicate this. Mi provide roadmap because health shouldn’t depend on income.

Beyond RSO: Broader product line mi e Guinea

While RSO focus, broader portfolio shows formulation range:

Peace Gummies: Born from Colin’s benzo withdrawal experience. Available e gummy nden vape forms. Particularly relevant e diaspora Guineen dealing e PTSD or prescription dependence.

Custom creations: Mi design products for specific needs — vegan formulations, diabetic-friendly options, targeted cannabinoid ratios. If you’re e Guinea e circumstances health unique, contact mi. Mi can create something specific.

Two product formats: Choosing what’s right e Guinea

Mi offer RSO e two delivery formats because different situations require different tools:

RSO Sublingual Oil ($129.99)

• Bottle 30 mL, 16,590 mg total cannabinoids
• Dropper graduated for precise dosing (0.1 mL increments = 55.3 mg cannabinoids)
• Onset: 15-45 minutes
• Duration: 4-6 hours
• Bioavailability: 13-19%
• ~40-60 doses per bottle

RSO Vape Cartridge ($49.99)

• Cartridge 1-gram, 900+ mg cannabinoids
• 510-thread: universal battery compatibility (batteries available globally)
• Onset: 1-2 minutes (fastest available)
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Instant THCa decarboxylation at vaping temperature

Which format e Guinea?

• Sublingual oil: Daily management chronic conditions, precise dosing, sustained relief
• Vape cartridge: Acute breakthrough pain, panic attacks, nausea from malaria medication, or situations requiring immediate relief

Guidance condition-specific e Guinea

Important disclaimer: These contexts informed by research cited e GENERAL KNOWLEDGE section. Ka medical prescriptions, not substitute for professional care e hospitals or clinics Guinea, nden not FDA-approved treatments. Always consult healthcare provider before using cannabinoid products, especially if you have medical conditions, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under psychoactive influence.

Nausea chemotherapy-related (e patients traveling Morocco or France e cancer treatment):

• Pre-chemo: 0.5-1.0 mL sublingual 1 hour before treatment
• Breakthrough nausea: 2-3 vape puffs for immediate relief
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)

Chronic pain (common agricultural workers e region Fouta Djallon Guinea):

• Daytime: 0.3-0.5 mL raw sublingual — anti-inflammatory without impairment e field work
• Nighttime: 0.5-1.0 mL decarboxylated sublingual — pain relief plus sleep support
• Breakthrough: Vape as needed for rapid relief

Sleep disorders (prevalent e urban Guinea due to heat, noise, stress):

• Before bed: 1.0-2.0 mL sublingual delivers 25-50 mg CBN, matching dosages research-supported

Anxiety nden stress (relevant e professionals urban Guinea nden diaspora):

• Daytime: 0.3 mL raw sublingual — CBD nden CBG e anxiety without high
• Nighttime: 1.0 mL sublingual — full profile including CBN e sleep architecture

General principle e Guinea: Start low, go slow. Begin e 0.25-0.5 mL sublingual (138-277 mg cannabinoids) nden assess effects over 2-3 hours before increasing. Individual responses vary based body weight, metabolism, nden tolerance.

Delivery e Guinea: How you get products mi

Mi operate only same-day RSO delivery system e Houston, but for Guinea, mi offer:

International shipping: Mi ship e Guinea e full documentation:

• Certificates of Analysis (COAs) for customs
• Detailed product receipts
• Hemp-derived product declarations
• Tracking information

Shipping details:

• Minimum flat fee applies (varies by carrier)
• Customer responsible for Guinea customs duties nden taxes
• Customer accepts all legal responsibility for import compliance
• Typical transit: 7-14 business days via international courier
• Temperature-stable packaging e climate tropical Guinea

What you need know about Guinean customs:

• Provide accurate recipient information (full name, address e Conakry or other city)
• Be prepared show ID upon delivery
• Customs may request additional documentation — mi provide everything possible, but final clearance beyond control
• Mi cannot guarantee delivery if Guinean law prohibits import, though legal framework suggests compliance should be possible

Payment: Mi accept international credit cards, PayPal, nden cryptocurrency e customers Guineen. Contact mi e (832) 416-2816 or [email protected] to arrange payment nden shipping.

How formulas connect e evidence

Every cannabinoid nden terpene e RSO formula has own evidence profile e GENERAL KNOWLEDGE section. Mi don’t exempt from same standards mi apply e broader field. When mi say product contains CBG, mi referencing pharmacology reviews showing CB1/CB2 interactions nden potential neuroprotective properties — but also acknowledging limited human clinical data. When mi include CBN at 750 mg, mi transparent that sleep evidence weaker than marketing suggests.

Honesty ɗum what makes content mi most trustworthy RSO education available e Guinea. Mi not here overwhelm you with jargon technical. Mi here give you best possible version information so you can give it fair shot nden decide if it’s right or wrong for you nden family.

RECOGNITION MEDIA: Why coverage ABC13 matters for Guinea

Between 2019 nden 2023, ABC13 Houston featured Colin Valencia e seven news segments. Five different reporters sought him out across four years. No other Houston cannabis operator has that track record. E customers Guineen, third-party validation from major American news organization establishes credibility self-promotion cannot.

Each feature addressed different aspects: CBD business boom, Delta-8 legality, COVID community health, criminal justice reform, nden Texas cannabis policy evolution. Consistent theme: Colin speaks honestly, even when uncomfortable. When ABC13 asked about Delta-8, o said, “Maybe you want get high” — radical honesty aired uncensored because it was true.

Most personally revealing moment came October 2022, when Colin disclosed own marijuana conviction history while discussing President Biden’s pardons. E customers Guineen who’ve lived under cannabis prohibition, revelation ɗum transforms every quote. When Colin says, “I would love see people not get hurt for this anymore,” o speaking from experience — not theory.

Media record cannot be purchased. It can only be earned through consistent, honest engagement over years. When you order from OilWell, you’re not buying from brand appeared yesterday. You’re buying from company major media trusts as authority.

SCIENCE: GENERAL KNOWLEDGE FOR GUINEA

How mi evaluate research

Mi prioritize evidence e this order: human clinical trials, systematic reviews, NIH institutional summaries, then literature preclinical. Hierarchy ɗum matters because evidence base uneven. CBD nden delta-9 THC have strongest human data; other compounds rely more on animal studies nden reviews.

E customers Guineen, this means when mi discuss CBG’s potential e neuroprotection, mi referencing 2021 pharmacology review showing CB1/CB2 interactions nden alpha-2 adrenoceptor activity — but also noting human studies sparse. When mi discuss CBN e sleep, mi citing 2021 review screened 99 human studies nden found no clinical trials using validated sleep measures. Honesty ɗum protects you from inflated expectations.

What major institutions say

U.S. National Center for Complementary and Integrative Health (NCCIH) states strongest cannabinoid evidence e for:

• Certain rare epilepsies (CBD)
• Chemotherapy-related nausea nden vomiting (THC)
• HIV/AIDS-related appetite nden weight loss (THC)

What they emphasize about safety:

• Impairment nden crash risk
• Cannabis use disorder potential
• Pregnancy concerns
• Contamination nden labeling inaccuracy
• Drug interactions (especially CBD)

E customers Guineen using multiple traditional nden modern medicines, warning interaction ɗum crucial. Always consult healthcare providers before combining cannabinoids e other treatments.

Profils cannabinoid

CBD: Most evidence-developed e formula mi. Strongest support e seizures, emerging support e anxiety nden pain, but safety concerns include liver enzyme elevation nden drug interactions. 2023 meta-analysis found real signals e drug-induced liver injury e some contexts [6].

CBG: Promising but clinically immature. 2021 pharmacology review notes it’s already commercially sold despite thin evidence [7]. Mi transparent about limitation ɗum.

Delta-8 THC: Psychoactive, less potent than delta-9, but e similar pharmacology [9]. 2023 scoping review found adverse consequence reports nden emphasized regulatory concerns [10]. Not “mild” cannabinoid — it’s real THC analogue e incomplete safety data.

THCa: Non-psychoactive precursor that converts ko THC e heat. 2016 review emphasizes interpretation depends on processing nden storage [12]. Design product mi preserves THCa specifically for flexibility ɗum.

Delta-9 THC: Strongest human evidence among psychoactive cannabinoids e nausea nden appetite, but clearest adverse-effect burden including mental health risks [13]-[15]. 2025 systematic review found consistent associations between high-concentration THC products nden psychosis/schizophrenia outcomes [15].

CBN: Marketing has outpaced evidence. 2021 sleep review found no clinical trials e validated measures [16]. 2024 cannabis-sleep review concluded research still doesn’t match real-world use scale [17]. Mi include it for theoretical synergy, not ko proven sleep cure.

CBC: Emerging evidence suggests distinct pharmacology nden potential relevance e pain nden inflammation, but 2024 review notes products already sold e little clinical efficacy or safety data [18].

Profils terpene: What aroma tells us

Live terpene blend 5% mi includes seven compounds, each e emerging but limited human evidence:

Limonene: Citrus-bright aroma. Review literature shows antioxidant nden anti-inflammatory potential, but most data preclinical [21]. Oxidation products can be allergens [22].

Myrcene: Earthy, musky. Preclinical studies suggest anxiolytic nden analgesic properties, but human evidence lacking [23].

Caryophyllene: Pepper/spice. Unique as dietary cannabinoid acting ko CB2 agonist [24]. Strongest terpene-cannabinoid connection, but still preclinical-dominant.

Pinene: Forest-fresh. Preclinical research on memory nden attention, but human trials absent [25].

Linalool: Floral, lavender. Preclinical evidence e stress nden mood, but clinical proof limited [26]. Oxidized forms can cause contact dermatitis [22].

Humulene: Earthy, woody. 2024 scoping review found preclinical anti-inflammatory evidence nden possible cannabimimetic activity, but no human trials [27].

Terpinolene: Piney, fruity. 2021 systematic review concluded evidence dominated by in silico nden animal studies, not human trials [28].

Research limits e Guinea

Evidence base highly uneven. Mi cannot let strong CBD seizure data stand ko weak CBN sleep data. Whole-cannabis extract evidence not apply e isolated molecules. Minor cannabinoids commercially interesting precisely because underexplored — but that means claims often inflated.

Product quality matters as much as molecule identity. Contamination, synthesis byproducts, nden dose variability all affect real-world outcomes [1][10][11][14]. E customers Guineen ordering internationally, lab testing mi addresses concerns directly.

Common overstatements mi avoid

• “CBN ko proven sleep aid” → More accurate: Evidence weak, no validated human trials [16][17]
• “Myrcene reliably causes sedation” → More accurate: Human proof limited, mostly preclinical [23]
• “Terpenes have proven entourage effects” → More accurate: Robust clinical proof remains limited [20][29]
• “THCa always non-psychoactive” → More accurate: Heat converts it ko THC [12]
• “Delta-8 safe because hemp-derived” → More accurate: It’s psychoactive e incomplete safety data [9]-[11]

RSO SUBLINGUAL OIL FORMULA: OPEN-SOURCE TRANSPARENCY

Complete formula for Guinea — use as product specification or DIY recipe:

Cannabinoid	Amount (mg)
CBD	4,500
CBG	3,000
Delta-8 THC	6,000
THCa	1,500
Delta-9 THC	90
CBN	750
CBC	750
TOTAL	16,590 mg

Additional specifications:

• Live terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: Bottle 30 mL
• Carrier: Organic MCT oil
• Active per mL: 553 mg cannabinoids
• Price: $129.99 USD
• Shipping to Guinea: Available e full documentation

E customers Guineen interested e DIY route: Source cannabinoid distillates from reputable suppliers (mi can recommend international vendors who ship e West Africa), blend according exact ratios e organic MCT oil, add cannabis-derived terpenes at 5% by volume. Result will be chemically identical e product mi. Ɗum promise mi e accessibility.

RSO VAPE CARTRIDGE FORMULA

Complete formula:

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%
Live terpenes	5%

Specifications:

• Format: Cartridge 1-gram
• 510-thread: Universal battery compatibility
• Price: $49.99 USD
• Shipping to Guinea: Available e COAs

Vape format particularly valuable e Guinea e situations acute — sudden pain flares, panic attacks, or breakthrough nausea — where waiting 15-45 minutes e sublingual onset not feasible.

TERPENE PROFILE: SENSORY DIMENSION

Both products contain same seven-terpene blend:

• Limonene: Citrus-bright, uplifting. Common e fruits citrus Guineen, familiar nden energizing.
• Myrcene: Earthy, grounding. Found e lemongrass used e traditional teas Guineen.
• Caryophyllene: Pepper/spice. Activates CB2 receptors, synergizes e cannabinoids.
• Pinene: Forest-fresh. Evokes highland forests Guinea, promotes clarity.
• Linalool: Floral, lavender-like. Calming, familiar from traditional aromatic plants.
• Humulene: Earthy, woody. Potential anti-inflammatory.
• Terpinolene: Piney, fruity, sparkling. Complex aroma profile.

Profile ɗum designed complement cannabinoid ratios while creating aroma nden taste experience feels natural, not artificial. E customers Guineen familiar e traditional herbal preparations, terpenes ɗe connect modern cannabinoid science ancestral plant knowledge.

FINAL WORDS FOR GUINEA

OilWell Cannabis exists because man refused let dog die. Refusal ɗum led ten years formulation experimentation, personal battles e PTSD nden addiction, nden commitment transparency publishing entire formulas represents. Mi featured on major American news because mi tell truth, even when uncomfortable. Mi given away $35,000 e product help community get vaccinated because health shared responsibility.

For customers mi e Guinea — whether you’re e Conakry, healthcare worker e Kankan, farmer e Mamou, or part diaspora sending support back home — mi offer same commitment: transparent formulas, honest education, nden products designed e real human suffering.

Evidence e document ɗum. Formulas published below. Choice yours.

Order today at oilwellcbd.com or contact mi e (832) 416-2816 / [email protected] arrange international shipping e Guinea. Mi here answer questions e English, provide documentation e customs, nden support journey with cannabinoids tested, transparent, nden grounded e both science nden compassion.

OilWell Cannabis: Houston-made, globally accessible, Guinea-ready.

ENGLISH

Rick Simpson Oil (RSO) in Guinea: The Complete Guide by OilWell Cannabis

Understanding Rick Simpson Oil: From Nova Scotia to Conakry

Who was Rick Simpson, and why does his story matter in Guinea?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada — a blue-collar tradesman who became the accidental godfather of concentrated cannabis oil. He wasn’t a doctor, scientist, or medical professional. He was a power engineer whose journey into cannabis medicine began the way so many journeys begin in Guinea: when conventional medicine failed him, and desperation forced him to look elsewhere.

In 1997, while working at a hospital in Moncton, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that doctors couldn’t resolve. The medications prescribed either didn’t help or made things worse. Sound familiar to anyone in Guinea who’s watched a loved one suffer after an accident, only to be told by doctors at Ignace Deen Hospital or Donka Hospital that there’s nothing more they can do? Simpson asked his doctor about cannabis and was refused — a scenario that still plays out in clinics across Conakry, Kankan, and Boké, where cannabis remains taboo despite its traditional use.

Simpson learned about a 1974 NIH study at the Medical College of Virginia where THC reportedly slowed tumors in mice. This became his foundational reference point, even though those findings were never replicated in controlled human trials — a critical distinction we must emphasize for our Guinea readers, where cancer treatment options at centers like Gamal Abdel Nasser University Hospital are already limited enough without false hope.

The pivotal moment came in 2003 when Simpson claimed that cannabis oil removed three skin cancer lesions on his arm within four days. No biopsy confirmation, no independent medical verification, no peer-reviewed documentation exists. But this personal testimony — not medical evidence — became the origin story of Rick Simpson Oil. For Guinean families facing impossible choices when a loved one receives a cancer diagnosis, this story resonates. We know because we’ve spoken with Guinean diaspora members in Houston who tell us about relatives back home in Kindia and Nzérékoré searching for any alternative when conventional treatment is unavailable or unaffordable.

Critical context: Simpson’s account is presented here as his personal testimony, not as clinical proof. The absence of medical documentation means these events cannot be evaluated as scientific evidence. They are, however, historically significant as the catalyst for a global movement that has now reached Guinea’s shores through online communities, diaspora networks, and the growing availability of hemp-derived products.

The crusade — spreading the oil across borders

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free — no charge, no profit motive. By his account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more.

This free-distribution model speaks directly to Guinea’s economic realities. When a 30 mL bottle of pharmaceutical-grade oil costs more than many families earn in a month, the ability to make medicine at home becomes not just preferable but essential. That’s why our open-source formula philosophy — publishing every milligram, every percentage, so you can source ingredients and make your own — directly echoes Simpson’s ethos for the modern era.

Simpson’s story exploded globally through the 2005 documentary Run From The Cure, distributed freely online. In Guinea, where internet penetration has grown dramatically through mobile networks, this film has circulated among cancer patient support groups on Facebook and WhatsApp. We’ve heard from Guinean medical students in Conakry who’ve watched it, from nurses in Labé sharing it with patients, and from families in Kissidougou discussing it as a last resort. The documentary became the RSO origin myth’s distribution mechanism, explaining why people in Guinea already know the term “RSO” even if they’ve never been to Nova Scotia.

But Simpson’s advocacy brought him into direct conflict with Canadian law. The RCMP raided his property in 2005 and 2009, charging him with cultivation, possession, and trafficking. He eventually left Canada for Europe, continuing his advocacy from Croatia and the Netherlands. This legal-risk narrative resonates in Guinea, where cannabis laws remain strict and enforcement unpredictable. When we talk about our Farm Bill compliance and third-party lab testing, we’re offering something Simpson never had: the ability to access RSO without fear of criminal consequences.

Traditional RSO protocol — the 60-gram regimen

Simpson’s core recommendation was consuming 60 grams of concentrated oil over approximately 90 days. For Guinean readers facing cancer, this protocol is often the first thing they encounter online. Let’s break it down honestly:

Week 1: Start with a dose the size of half a grain of rice — about 10-15 mg — three times daily. Total: 30-45 mg per day. This is actually a reasonable starting point for cannabinoid-naive patients anywhere, including Guinea.

Weeks 2-5: Double the dose every four days to build tolerance. By week five, target 1 gram (1,000 mg) per day, divided into three doses.

Weeks 5-12: Maintain 1 gram daily until all 60 grams are consumed. At 600-900 mg of THC per day (assuming 60-90% THC oil), this is 30-60 times higher than FDA-approved dronabinol doses.

Critical context for evaluating this protocol:

• No controlled trial validation exists anywhere, including in Guinea’s research institutions
• The crude, unstandardized material means potency varies wildly — a problem our lab-tested formulations specifically solve
• At peak dosing, patients consume 600-900 mg of delta-9 THC daily, carrying severe risks: intoxication, anxiety, panic, tachycardia, hypotension, and cannabis use disorder
• Patients with active cancer are medically complex; using unregulated oil as primary treatment could mean delaying or foregoing proven therapies available at Guinea’s National Hospital or regional medical centers

What traditional RSO actually was

Source material: Single high-THC indica strain, no standardization. In Guinea, where cannabis cultivation exists in traditional contexts but lacks genetic standardization, this variability is well-understood. Our multi-cannabinoid approach using distillates from multiple sources is the modern evolution.

Extraction solvent: Naphtha (petroleum-based) or 99% isopropyl alcohol — neither food-grade. This is the #1 safety improvement in modern RSO. In Guinea’s climate, where solvents evaporate quickly and fire risks are real, using food-grade ethanol or CO₂ is even more critical.

Appearance: Nearly black, thick, tar-like oil with possible solvent-residual smell. In Conakry’s heat and humidity, this consistency becomes even more difficult to handle. Our MCT oil base provides a stable, pourable solution that works in Guinea’s tropical climate.

Cannabinoid profile: 60-90% delta-9 THC, uncontrolled, never lab-verified. At Ignace Deen Hospital, doctors would never administer a medicine without knowing its exact concentration. Why should cannabis oil be different?

Terpene content: Minimal to none. The heat destroyed them. In Guinea, where aromatic plants like lemongrass, eucalyptus, and cloves are part of traditional medicine, losing therapeutic terpenes is like discarding half the medicine. Our 5% live terpene profile preserves these compounds.

Simpson’s claims vs. the evidence record

Simpson claimed RSO could cure cancer and dozens of other diseases. Let’s be unequivocally clear for our Guinean readers:

What the preclinical literature shows: In vitro and animal studies demonstrate THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines. Animal models show some tumor-growth inhibition. This research is real and ongoing at institutions worldwide, including some African universities studying traditional medicines.

What it does NOT show: These findings have NOT translated into proven human cancer cures. No human clinical trial has demonstrated that RSO or any cannabis oil cures cancer. The gap between lab results and human outcomes is vast across all oncology research.

Institutional positions:

• U.S. National Cancer Institute acknowledges anticancer research but does NOT endorse cannabis as cancer treatment
• FDA has NOT approved any cannabis plant product for cancer
• Health Canada has NEVER approved RSO for cancer
• NCCIH identifies strongest evidence for epilepsy, chemo nausea, and HIV/AIDS appetite — not cancer cure

What Simpson got right: He drew attention to cannabinoids as serious biomedical research when the world ignored them. He created conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated: Cancer cure claims exceed the evidence. Encouraging patients to use RSO instead of proven therapies carries genuine harm potential. In Guinea, where oncology resources are already scarce, delaying effective treatment at Donka Hospital or Gamal Abdel Nasser University Hospital for unproven alternatives could be fatal.

ABOUT OILWELL CANNABIS AND OUR RSO FORMULA FOR GUINEA

Our origin story: From McAllen to Montrose to Conakry

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen, Texas — one of the most economically challenged and dangerous border regions in America. The McAllen-Reynosa Borderplex taught him what it means to survive when systems fail, when violence is routine, and when opportunity seems nonexistent. By sixteen, he’d left home for good. Many of his best friends were killed or imprisoned. He faced every form of violence imaginable.

This background isn’t just a story — it’s why we understand what Guinean families endure when healthcare systems don’t meet their needs. When we hear from customers in Conakry about loved ones suffering because medications are unavailable or unaffordable, we recognize that reality. Colin chose cannabis over darker paths because he saw it as a safer, more beneficial alternative. That choice — made in the shadows before legalization — informs every product we make today.

Colin later became a formally trained software engineer, doing custom development for Baylor College of Medicine in the Texas Medical Center. That combination — deep cannabis plant knowledge from the underground plus medical-grade technical precision — defines our approach. When Guinean medical professionals reach out to us asking about our formulas, we can speak their language because we’ve worked alongside some of America’s finest medical institutions.

Bentley: The dog who started everything

Our company began with Bentley, a paralyzed dog facing euthanasia. Veterinarians said pain medications would destroy his organs. The only humane option was ending his life. Colin refused. He’d already lost too much. Bentley was family.

Through a rescue worker’s question — “You’ve moved how many tons of weed and you’ve never heard of CBD?” — Colin discovered therapeutic cannabinoids. He created CBD golden paste. Bentley got up. He walked. He brought his ball to play. Dogs don’t respond to placebo. This was real medicine doing what pharmaceuticals could not.

Bentley lived ten more years, dying naturally at age twenty. During those years, Colin developed formulas for every condition Bentley faced: neurodegeneration (CBG neuroprotection, THCa PPARγ agonism), dementia (CBC neurogenesis), glaucoma (THC CB1 agonism), arthritis (multi-pathway anti-inflammatory). This wasn’t theoretical research — it was keeping a loved one alive. That same formulation knowledge is now available to Guinean families seeking options for aging parents or relatives with chronic conditions.

Single cannabinoids weren’t enough for Bentley. Neither are they for most humans. That’s why our RSO contains seven cannabinoids at specific ratios — because real patients have multiple, evolving needs that one molecule cannot address.

From personal crisis to professional mission

Colin knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. He quit Xanax cold turkey — a dangerous feat — using the same cannabinoid knowledge that saved Bentley. Our Peace Gummies formula was created during midnight experiments while fighting benzo withdrawal. Colin still uses the vape form for his insomnia and severe PTSD.

This is not corporate marketing. This is lived experience. When Guinean veterans who served in peacekeeping missions reach out about PTSD, when families ask about tapering off prescription medications, when chronic pain sufferers describe being failed by conventional treatments — we understand because we’ve been there. Our products aren’t designed in a boardroom; they’re formulated by someone who survived what our customers are surviving.

Recognition from Houston to Guinea

ABC13 Houston, America’s fourth-largest news market, featured Colin in seven comprehensive segments from 2019 to 2023. That’s not paid advertising — it’s editorial judgment that he’s the most credible voice in the industry. The coverage spanned business, law, medicine, community health, and politics. Five different reporters sought him out because when Texans needed honest cannabis information, Colin delivered.

This matters for Guinea because it demonstrates third-party validation that transcends self-promotion. When a major American news organization repeatedly chooses one person as their expert, it signals that this isn’t another online cannabis brand making unsubstantiated claims. Our 2019 foundational quote captured our ethos: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

That philosophy — education over hype, transparency over mystery — is what Guinean consumers deserve.

Our operational commitment

Today, OilWell operates from Montrose, Houston (810 Richmond Avenue, Houston, TX 77006). We’ve been in business since 2019, maintain a near-perfect Google rating, and hold a Texas DSHS license. We generate approximately $1 million annually not by mass production, but by carefully crafting every product with personal touch. All artwork, formulations, and packaging are created in-house in Houston. We bring McAllen grit, Houston determination, and a builder’s mindset to everything we do.

For Guinean customers, this means you’re getting products from a real, successful, licensed American business — not a fly-by-night operation. We can provide documentation, Certificates of Analysis, and consistent quality that informal suppliers in Guinea cannot match.

Four core principles that define our RSO for Guinea

Our RSO formulas aren’t traditional Rick Simpson Oil. They’re informed by his tradition but deliberately evolved to solve the problems that limited his original vision:

1. Accessibility over gatekeeping. No medical card is required. Anyone age twenty-one or older can purchase. We ship nationwide across the United States and internationally to Guinea. Simpson believed medicine should be accessible to everyone; we built a distribution model that makes that legally possible.

2. Patient-controlled potency. Our oil contains THCa in its acidic, non-psychoactive form. You decide whether to use it raw (zero impairment, perfect for daytime) or decarboxylate it into delta-9 THC (full psychoactive potency, ideal for nighttime). Simpson believed patients should control their medicine; we engineered product chemistry that puts that control in your hands.

3. Open-source formulas. We publish our complete formulas publicly — every cannabinoid, every milligram — so that if a 30 mL bottle at $129.99 is beyond your budget in Guinea, you can source ingredients and make your own version. Simpson gave his oil away free and taught people to make it; we adapted that ethos for the modern global marketplace.

4. Evidence-informed, not evidence-overstating. The scientific research documented in the GENERAL KNOWLEDGE section of this guide represents our commitment to honest education about what science actually supports. Simpson operated without peer-reviewed literature; we have access to that literature and use it to distinguish well-supported claims from emerging hypotheses from outright overstatements.

Legal framework: Farm Bill compliance and THCa in Guinea

The 2018 U.S. Farm Bill legalized hemp products containing less than 0.3% delta-9 THC at the federal level. Our RSO Sublingual Oil contains only 90 mg of delta-9 THC in the entire 30 mL bottle — 3 mg per mL — well under the threshold. All cannabinoids are hemp-derived. This makes the product legal under U.S. federal law and in most states.

THCa (tetrahydrocannabinolic acid) is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC, making it Farm Bill compliant at point of sale. This distinction is crucial for Guinean customers because it creates three distinct usage options from one product:

• Raw (no heat): All 1,500 mg stays as THCa — completely non-psychoactive, suitable for work, driving, parenting, and daytime use in Guinea’s active lifestyle
• Fully activated: Heat at 260°F (125°C) for 45-60 minutes converts 1,500 mg THCa into ~1,315 mg delta-9 THC. Combined with the existing 90 mg, this yields ~1,405 mg total delta-9 THC — psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after purchase
• Vape: The RSO Vape Cartridge instantly decarboxylates THCa at 400-450°F, delivering freshly activated cannabinoids with each puff

Important legal notice for Guinea: THCa converts to delta-9 THC when heated. Guinean customers are responsible for understanding and complying with local laws regarding cannabinoid products. We ship with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal responsibility. While our product meets U.S. legal standards at export, you must verify its status under Guinean law upon import.

Guinea’s legal framework for cannabis is evolving. As of our latest information, cannabis remains regulated under national drug control laws. However, hemp-derived products with minimal THC content may fall into a different category. We strongly advise consulting with local authorities or legal counsel in Conakry before ordering.

The decarboxylation choice: Your power in Guinea

Traditional RSO was always fully decarboxylated — always psychoactive, no choice. Our formula preserves THCa as a distinct ingredient, giving you control that matters deeply in Guinea’s context:

• For farmers in Faranah who need daytime pain relief without impairment: use it raw
• For office workers in Kaloum managing anxiety: a few drops under the tongue, no high
• For cancer patients in Conakry needing full therapeutic strength: decarboxylate at home for maximum potency
• For veterans in Kindia with PTSD: the vape provides instant relief when symptoms strike

The conversion chemistry is straightforward: 1 mg THCa = 0.877 mg delta-9 THC after heating. Our 1,500 mg THCa yields ~1,315 mg delta-9 when fully activated. This means the same legal product can function as a non-psychoactive anti-inflammatory or full-potency psychoactive medicine — your choice, not ours.

Solvent-free production: Safety you can verify

Traditional RSO used naphtha or isopropyl alcohol — toxic, non-food-grade solvents that leave harmful residues. In Guinea’s hot climate, solvent evaporation is faster but incomplete purging is still impossible to verify without lab equipment.

Our production uses no solvents. We blend individual cannabinoid distillates and isolates in a controlled environment. The carrier is organic MCT oil, a food-grade lipid that facilitates absorption and provides stability in Guinea’s tropical conditions. No tar-like consistency, no chemical odor, no guessing about purity.

Third-party lab testing covers:

• Cannabinoid potency verification
• Terpene profile confirmation
• Pesticide screening (400+ compounds)
• Heavy metals (arsenic, cadmium, lead, mercury)
• Residual solvents
• Microbial contaminants

Certificates of Analysis are available on request and through our website. For Guinean customers, this documentation provides assurance that what you’re putting in your body has been verified by independent American laboratories — a standard of safety that informal local products cannot match.

Open-source formulas: Transparency for Guinea

We publish our complete formulas because Simpson gave his oil away free and taught people to make it. That ethos of accessibility drives us. If $129.99 for a 30 mL bottle is beyond your reach in Guinea, here’s exactly what’s in it:

RSO Sublingual Oil Formula

• CBD: 4,500 mg
• CBG: 3,000 mg
• Delta-8 THC: 6,000 mg
• THCa: 1,500 mg
• Delta-9 THC: 90 mg
• CBN: 750 mg
• CBC: 750 mg
• Total: 16,590 mg cannabinoids in 30 mL (553 mg/mL)
• Live terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil

This is simultaneously a product specification, an educational tool, and a recipe. Guinean customers with access to cannabinoid distillates can replicate this. We provide the roadmap because your health shouldn’t depend on your income.

Beyond RSO: Our broader product line for Guinea

While RSO is our focus, our broader portfolio shows our formulation range:

Peace Gummies: Born from Colin’s benzo withdrawal experience. Available in gummy and vape forms. Particularly relevant for Guinean diaspora members dealing with PTSD or prescription dependence.

Custom creations: We design products for specific needs — vegan formulations, diabetic-friendly options, targeted cannabinoid ratios. If you’re in Guinea with unique health circumstances, contact us. We can create something specific.

Two product formats: Choosing what’s right for Guinea

We offer RSO in two delivery formats because different situations require different tools:

RSO Sublingual Oil ($129.99)

• 30 mL bottle, 16,590 mg total cannabinoids
• Graduated dropper for precise dosing (0.1 mL increments = 55.3 mg cannabinoids)
• Onset: 15-45 minutes
• Duration: 4-6 hours
• Bioavailability: 13-19%
• ~40-60 doses per bottle

RSO Vape Cartridge ($49.99)

• 1-gram cartridge, 900+ mg cannabinoids
• 510-thread universal battery compatibility (batteries available globally)
• Onset: 1-2 minutes (fastest available)
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Instant THCa decarboxylation at vaping temperature

Which format for Guinea?

• Sublingual oil: Daily management of chronic conditions, precise dosing, sustained relief
• Vape cartridge: Acute breakthrough pain, panic attacks, nausea from malaria medication, or situations requiring immediate relief

Condition-specific guidance for Guinea

Important disclaimer: These contexts are informed by research cited in our GENERAL KNOWLEDGE section. They are not medical prescriptions, not a substitute for professional care at Guinea’s hospitals or clinics, and not FDA-approved treatments. Always consult a healthcare provider before using cannabinoid products, especially if you have medical conditions, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under psychoactive influence.

Chemotherapy-related nausea (for patients traveling to Morocco or France for cancer treatment):

• Pre-chemo: 0.5-1.0 mL sublingual 1 hour before treatment
• Breakthrough nausea: 2-3 vape puffs for immediate relief
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)

Chronic pain (common among agricultural workers in Guinea’s Fouta Djallon region):

• Daytime: 0.3-0.5 mL raw sublingual — anti-inflammatory without impairment for field work
• Nighttime: 0.5-1.0 mL decarboxylated sublingual — pain relief plus sleep support
• Breakthrough: Vape as needed for rapid relief

Sleep disorders (prevalent in urban Guinea due to heat, noise, stress):

• Before bed: 1.0-2.0 mL sublingual delivers 25-50 mg CBN, matching research-supported dosages

Anxiety and stress (relevant for Guinea’s urban professionals and diaspora):

• Daytime: 0.3 mL raw sublingual — CBD and CBG for anxiety without high
• Nighttime: 1.0 mL sublingual — full profile including CBN for sleep architecture

General principle for Guinea: Start low, go slow. Begin with 0.25-0.5 mL sublingual (138-277 mg cannabinoids) and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, and tolerance.

Delivery to Guinea: How you get our products

We operate the only same-day RSO delivery system in Houston, but for Guinea, we offer:

International shipping: We ship to Guinea with full documentation:

• Certificates of Analysis (COAs) for customs
• Detailed product receipts
• Hemp-derived product declarations
• Tracking information

Shipping details:

• Minimum flat fee applies (varies by carrier)
• Customer responsible for Guinea customs duties and taxes
• Customer accepts all legal responsibility for import compliance
• Typical transit: 7-14 business days via international courier
• Temperature-stable packaging for Guinea’s tropical climate

What you need to know about Guinean customs:

• Provide accurate recipient information (full name, address in Conakry or other city)
• Be prepared to show ID upon delivery
• Customs may request additional documentation — we provide everything possible, but final clearance is beyond our control
• We cannot guarantee delivery if Guinean law prohibits import, though our legal framework suggests compliance should be possible

Payment: We accept international credit cards, PayPal, and cryptocurrency for Guinean customers. Contact us at (832) 416-2816 or [email protected] to arrange payment and shipping.

How our formulas connect to the evidence

Every cannabinoid and terpene in our RSO formula has its own evidence profile in our GENERAL KNOWLEDGE section. We don’t exempt ourselves from the same standards we apply to the broader field. When we say our product contains CBG, we’re referencing the pharmacology reviews showing its CB1/CB2 interactions and potential neuroprotective properties — but also acknowledging the limited human clinical data. When we include CBN at 750 mg, we’re transparent that the sleep evidence is weaker than marketing suggests.

This honesty is what makes our content the most trustworthy RSO education available in Guinea. We’re not here to overwhelm you with technical jargon. We’re here to give you the best possible version of the information so you can give it a fair shot and decide if it’s right or wrong for you and your family.

MEDIA RECOGNITION: Why ABC13’s coverage matters for Guinea

Between 2019 and 2023, ABC13 Houston featured Colin Valencia in seven news segments. Five different reporters sought him out across four years. No other Houston cannabis operator has that track record. For Guinean customers, this third-party validation from a major American news organization establishes credibility that self-promotion cannot.

Each feature addressed different aspects: CBD business boom, Delta-8 legality, COVID community health, criminal justice reform, and Texas cannabis policy evolution. The consistent theme: Colin speaks honestly, even when it’s uncomfortable. When ABC13 asked about Delta-8, he said, “Maybe you want to get high” — radical honesty that aired uncensored because it was true.

The most personally revealing moment came in October 2022, when Colin disclosed his own marijuana conviction history while discussing President Biden’s pardons. For Guinean customers who’ve lived under cannabis prohibition, this revelation transforms every quote. When Colin says, “I would love to see people not get hurt for this anymore,” he’s speaking from experience — not theory.

This media record cannot be purchased. It can only be earned through consistent, honest engagement over years. When you order from OilWell, you’re not buying from a brand that appeared yesterday. You’re buying from a company that major media trusts as an authority.

THE SCIENCE: GENERAL KNOWLEDGE FOR GUINEA

How we evaluate research

We prioritize evidence in this order: human clinical trials, systematic reviews, NIH institutional summaries, then preclinical literature. This hierarchy matters because the evidence base is uneven. CBD and delta-9 THC have the strongest human data; other compounds rely more on animal studies and reviews.

For Guinean customers, this means when we discuss CBG’s potential for neuroprotection, we’re referencing the 2021 pharmacology review showing CB1/CB2 interactions and alpha-2 adrenoceptor activity — but also noting that human studies are sparse. When we discuss CBN for sleep, we’re citing the 2021 review that screened 99 human studies and found no clinical trials using validated sleep measures. This honesty protects you from inflated expectations.

What major institutions say

The U.S. National Center for Complementary and Integrative Health (NCCIH) states that the strongest cannabinoid evidence is for:

• Certain rare epilepsies (CBD)
• Chemotherapy-related nausea and vomiting (THC)
• HIV/AIDS-related appetite and weight loss (THC)

What they emphasize about safety:

• Impairment and crash risk
• Cannabis use disorder potential
• Pregnancy concerns
• Contamination and labeling inaccuracy
• Drug interactions (especially CBD)

For Guinean customers using multiple traditional and modern medicines, that interaction warning is crucial. Always consult healthcare providers before combining cannabinoids with other treatments.

Cannabinoid profiles

CBD: Most evidence-developed in our formula. Strongest support for seizures, emerging support for anxiety and pain, but safety concerns include liver enzyme elevation and drug interactions. The 2023 meta-analysis found real signals for drug-induced liver injury in some contexts [6].

CBG: Promising but clinically immature. The 2021 pharmacology review notes it’s already commercially sold despite thin evidence [7]. We’re transparent about this limitation.

Delta-8 THC: Psychoactive, less potent than delta-9, but with similar pharmacology [9]. The 2023 scoping review found adverse consequence reports and emphasized regulatory concerns [10]. Not a “mild” cannabinoid — it’s a real THC analogue with incomplete safety data.

THCa: Non-psychoactive precursor that converts to THC with heat. The 2016 review emphasizes that interpretation depends on processing and storage [12]. Our product design preserves THCa specifically for this flexibility.

Delta-9 THC: Strongest human evidence among psychoactive cannabinoids for nausea and appetite, but clearest adverse-effect burden including mental health risks [13]-[15]. The 2025 systematic review found consistent associations between high-concentration THC products and psychosis/schizophrenia outcomes [15].

CBN: Marketing has outpaced evidence. The 2021 sleep review found no clinical trials with validated measures [16]. The 2024 cannabis-sleep review concluded research still doesn’t match real-world use scale [17]. We include it for its theoretical synergy, not as a proven sleep cure.

CBC: Emerging evidence suggests distinct pharmacology and potential relevance to pain and inflammation, but the 2024 review notes products are already being sold with little clinical efficacy or safety data [18].

Terpene profiles: What the aroma tells us

Our 5% live terpene blend includes seven compounds, each with emerging but limited human evidence:

Limonene: Citrus-bright aroma. Review literature shows antioxidant and anti-inflammatory potential, but most data are preclinical [21]. The oxidation products can be allergens [22].

Myrcene: Earthy, musky. Preclinical studies suggest anxiolytic and analgesic properties, but human evidence is lacking [23].

Caryophyllene: Pepper/spice. Unique as a dietary cannabinoid that acts as CB2 agonist [24]. Strongest terpene-cannabinoid connection, but still preclinical-dominant.

Pinene: Forest-fresh. Preclinical research on memory and attention, but human trials are absent [25].

Linalool: Floral, lavender. Preclinical evidence for stress and mood, but clinical proof is limited [26]. Oxidized forms can cause contact dermatitis [22].

Humulene: Earthy, woody. 2024 scoping review found preclinical anti-inflammatory evidence and possible cannabimimetic activity, but no human trials [27].

Terpinolene: Piney, fruity. 2021 systematic review concluded evidence is dominated by in silico and animal studies, not human trials [28].

Research limits for Guinea

The evidence base is highly uneven. We cannot let strong CBD seizure data stand in for weak CBN sleep data. Whole-cannabis extract evidence doesn’t apply to isolated molecules. Minor cannabinoids are commercially interesting precisely because they’re underexplored — but that means claims are often inflated.

Product quality matters as much as molecule identity. Contamination, synthesis byproducts, and dose variability all affect real-world outcomes [1][10][11][14]. For Guinean customers ordering internationally, our lab testing addresses these concerns directly.

Common overstatements we avoid

• “CBN is a proven sleep aid” → More accurate: Evidence is weak, no validated human trials [16][17]
• “Myrcene reliably causes sedation” → More accurate: Human proof is limited, mostly preclinical [23]
• “Terpenes have proven entourage effects” → More accurate: Robust clinical proof remains limited [20][29]
• “THCa is always non-psychoactive” → More accurate: Heat converts it to THC [12]
• “Delta-8 is safe because it’s hemp-derived” → More accurate: It’s psychoactive with incomplete safety data [9]-[11]

RSO SUBLINGUAL OIL FORMULA: OPEN-SOURCE TRANSPARENCY

Complete formula for Guinea – use as product specification or DIY recipe:

Cannabinoid	Amount (mg)
CBD	4,500
CBG	3,000
Delta-8 THC	6,000
THCa	1,500
Delta-9 THC	90
CBN	750
CBC	750
TOTAL	16,590 mg

Additional specifications:

• Live terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30 mL bottle
• Carrier: Organic MCT oil
• Active per mL: 553 mg cannabinoids
• Price: $129.99 USD
• Shipping to Guinea: Available with full documentation

For Guinean customers interested in the DIY route: Source cannabinoid distillates from reputable suppliers (we can recommend international vendors who ship to West Africa), blend according to these exact ratios in organic MCT oil, add cannabis-derived terpenes at 5% by volume. The result will be chemically identical to our product. This is our promise to accessibility.

RSO VAPE CARTRIDGE FORMULA

Complete formula:

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%
Live terpenes	5%

Specifications:

• Format: 1-gram cartridge
• 510-thread: Universal battery compatibility
• Price: $49.99 USD
• Shipping to Guinea: Available with COAs

The vape format is particularly valuable in Guinea for acute situations — sudden pain flares, panic attacks, or breakthrough nausea — where waiting 15-45 minutes for sublingual onset isn’t feasible.

TERPENE PROFILE: THE SENORY DIMENSION

Both products contain the same seven-terpene blend:

• Limonene: Citrus-bright, uplifting. Common in Guinean citrus fruits, familiar and energizing.
• Myrcene: Earthy, grounding. Found in lemongrass used in Guinean traditional teas.
• Caryophyllene: Pepper/spice. Activates CB2 receptors, synergizes with cannabinoids.
• Pinene: Forest-fresh. Evokes Guinea’s highland forests, promotes clarity.
• Linalool: Floral, lavender-like. Calming, familiar from traditional aromatic plants.
• Humulene: Earthy, woody. Anti-inflammatory potential.
• Terpinolene: Piney, fruity, sparkling. Complex aroma profile.

This profile was designed to complement our cannabinoid ratios while creating an aroma and taste experience that feels natural, not artificial. For Guinean customers familiar with traditional herbal preparations, these terpenes connect modern cannabinoid science to ancestral plant knowledge.

FINAL WORDS FOR GUINEA

OilWell Cannabis exists because a man refused to let his dog die. That refusal led to ten years of formulation experimentation, personal battles with PTSD and addiction, and a commitment to transparency that publishing entire formulas represents. We’ve been featured on major American news because we tell the truth, even when it’s uncomfortable. We’ve given away $35,000 in product to help our community get vaccinated because health is a shared responsibility.

For our customers in Guinea — whether you’re in Conakry, a healthcare worker in Kankan, a farmer in Mamou, or part of the diaspora sending support back home — we offer the same commitment: transparent formulas, honest education, and products designed for real human suffering.

The evidence is in this document. The formulas are published below. The choice is yours.

Order today at oilwellcbd.com or contact us at (832) 416-2816 / [email protected] to arrange international shipping to Guinea. We’re here to answer your questions in English, provide documentation for customs, and support your journey with cannabinoids that are tested, transparent, and grounded in both science and compassion.

OilWell Cannabis: Houston-made, globally accessible, Guinea-ready.

---